NIH-funded research R01 grant

Understanding lupus risk across diverse populations to improve early diagnosis

Official title: Integrative approaches to understand systemic lupus erythematosus etiology in trans-ancestry genetic studies

Funded at Pennsylvania State Univ Hershey Med Ctr · NIH-11160721 · Data updated 2026-11-12

A team will combine genetic data from many populations to improve how we predict who is at risk for lupus and how early it can be diagnosed.

More Lupus research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionPennsylvania State Univ Hershey Med Ctr
NIH-funded
Lab location1 site (Hershey, United States)
Project startSeptember 20, 2022
Project endJuly 31, 2028
Funding year2026
Award (this year)$706,616
NIH project number5R01AI174108-04
Project IDNIH-11160721 on NIH RePORTER

Who could benefit from this research

Could help

Patients with lupus or individuals at risk due to family history or genetic factors may benefit from improved risk prediction and earlier diagnosis.

Less likely to help

People without lupus risk factors or those not involved in genetic risk profiling may not directly benefit.

What this research studies

This project brings together genetic data from people of different ancestries to refine the genetic variants linked to lupus and to build more accurate risk scores. Researchers will create and test new methods that combine data from multiple autoimmune diseases and ancestries, helping to identify causal variants more precisely. They will also validate these findings with experiments and aim to share software tools so other researchers can apply the approach to lupus and related conditions. The work has potential implications for earlier diagnosis, personalized risk assessment, and better understanding of disease biology.

Why it matters

Potential benefit: If successful, the research could lead to earlier and more accurate lupus risk prediction and support personalized monitoring and preventive strategies.

How similar studies have gone: Previous lupus GWAS have identified many risk loci, and meta-analytic approaches across diverse populations have shown promise in improving fine-mapping and risk prediction.

Where this research is happening

  • Pennsylvania State Univ Hershey Med Ctr
    Hershey, United States
    Active

Researchers

  • Principal investigator: Liu, Dajiang — Pennsylvania State Univ Hershey Med Ctr
  • Study coordinator: Liu, Dajiang

Related research

Other NIH-funded projects on the same topics.

  • Immunostimulatory short non-coding RNAs and lupus

    A study in people with lupus looks at tiny RNA pieces that may spark inflammation, to understand if they drive disease activity.

    NIH research Thomas Jefferson University · Philadelphia, United States · NIH-11497703

  • Antiviral factors that limit HIV in people with SLE

    Researchers at Howard University are studying how immune factors in people with lupus may help limit HIV infection.

    NIH research Howard University · Washington, United States · NIH-11470887

  • Mechanistic clues about lupus from immune disorders

    This grant looks at why certain immune disorders in people with genetic immune problems lead to lupus-like symptoms, by studying patients and mouse models.

    NIH research Seattle Children's Hospital · Seattle, United States · NIH-11449228

  • Subjective thinking challenges in adults with lupus as they age

    This grant aims to understand how lupus-related cognitive problems affect adults, especially older adults, and tests a real-time method to track daily fluctuations in those symptoms.

    NIH research Hospital for Special Surgery · New York, UNITED STATES · NIH-11442899

  • Mitochondrial targets of antibodies in lupus (SLE)

    A Johns Hopkins-led study will identify which mitochondrial membrane proteins are targeted by autoantibodies in lupus patients to understand how these immune attacks fuel the disease.

    NIH research Johns Hopkins University · Baltimore, United States · NIH-11440181

  • Influenza, Hydroxychloroquine, and the Windows of Self-Peptide Presentation in Lupus

    A doctor-researcher is studying how flu infection and the lupus medication hydroxychloroquine change the way the immune system shows self-parts to trigger or prevent lupus flares in kids.

    NIH research Children's Hosp of Philadelphia · Philadelphia, United States · NIH-11438703

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.